Combating Buruli Ulcer: WHO’s Efforts in Nigeria

Angela Dukpe, a resident of Nigeria, developed Buruli Ulcer after a painless nodule on her leg transformed into an extensive sore. WHO and Nigeria’s Federal Ministry of Health are actively working to combat Buruli Ulcer through public health initiatives and treatment support. This neglected tropical disease affects millions, but community education and early detection can mitigate its impact.
On February 24, 2025, in Makurdi, Nigeria, 57-year-old Angela Dukpe experienced a grave health issue when a painless nodule on her left leg turned into a foul-smelling sore. Angela initially ignored the lump, which eventually caused distress to her self-esteem and disrupted her family life. A traditional healer alerted a Disease Surveillance and Notification Officer, Mr. Ikyoto Sylvanus, who identified the wound as resembling Buruli Ulcer and initiated a laboratory test.
Buruli Ulcer is classified among the 17 Neglected Tropical Diseases by the World Health Organization, affecting over 120 million individuals in 72 countries, with Nigeria being significantly impacted. This infectious disease primarily targets the skin and soft tissues, leading to potential disabilities and disfigurements if untreated. In 2024, Nigeria reported 698 suspected cases, which often begin as painless swellings, primarily situated on limbs and the face.
The disease commonly proliferates in rural, marshy regions, particularly affecting children under 15 years of age. Symptoms may progress without pain or fever, underscoring the critical need for early detection and treatment. Effective management should include a combination of antibiotics and supportive therapies in the initial stages, yet many affected people remain uninformed about available treatment options.
The WHO, in partnership with the Nigerian Federal Ministry of Health, is pivotal in battling Buruli Ulcer and other NTDs by enhancing diagnostic and treatment protocols. They offer technical, financial, and logistical support aimed at improving disease surveillance and access to treatment. In Benue State, WHO has aided local authorities in actively searching for cases and facilitating laboratory testing.
“WHO has supported sensitization campaigns to educate communities on seeking healthcare early for Buruli Ulcer before complications arise,” explained Mr. Ikyoto. He emphasized the challenges faced by the health system in treating the numerous identified cases.
During the commemoration of the 2025 World NTDs Day, Nigeria’s Minister of State for Health, Dr. Iziaq Salako, highlighted that over 200 million Nigerians are at risk of at least one NTD. He noted that the WHO’s 10-year NTDs roadmap aims for significant targets to ensure access to care and prevention for all citizens.
WHO Country Representative Dr. Walter Kazadi Mulombo urged collaborative action to eradicate NTDs through significant and sustainable investments. He clarified, “Buruli Ulcer is a major contributor to morbidity and suffering, impacting both life quality and national productivity.” He called on all sectors, including communities, governments, and civil societies, to address this neglected ailment.
The collaboration between WHO and the Nigerian government is crucial in combating Buruli Ulcer, especially in rural communities. Public awareness campaigns have proven effective in early detection and treatment. However, significant gaps in funding and resources remain, highlighting the need for sustained efforts to ensure access to healthcare for all affected individuals. A collective commitment from communities and stakeholders is essential to address and eliminate this debilitating disease.
Original Source: www.afro.who.int